Noticias Evgen Pharma - EVG

Nombre de la Acción	Símbolo de la Acción	Bolsa de Valores	Tipo de Valor
Evgen Pharma Plc	EVG	London	Acción Ordinaria

	Variación del Día (ptos.)	Variación del Día (%)	Último Precio	Hora
	0.00	0.0%	1.70	02:00:00

Precio de Apertura	Precio Mínimo	Precio Máximo	Precio de cierre	Precio Anterior
1.70	1.70	1.70	1.70	1.70

más cotizaciones de acciones »

Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha	Hora	Fuente	Noticia
13/11/2023	01:00	RNSNON	Evgen Pharma PLC Upcoming conferences
31/10/2023	09:38	ALNC	TRADING UPDATES: Acuity RM wins contract; Georgia Capital..
31/10/2023	02:00	UKREG	Evgen Pharma PLC Half-year Report
26/10/2023	01:00	RNSNON	Evgen Pharma PLC Erasmus Medical Center begins glioblastoma..
19/10/2023	13:39	ALNC	IN BRIEF: Evgen showcases importance of new enteric-coated..
19/10/2023	08:26	RNSNON	Evgen Pharma PLC Authored Article Publication
05/9/2023	08:22	ALNC	Evgen Pharma hires interim CFO from Faron, chair to retire..
05/9/2023	01:00	UKREG	Evgen Pharma PLC Directorate Changes
15/8/2023	04:01	ALNC	Evgen Pharma says trial shows new SFX-01 drug formulation is..
15/8/2023	01:00	UKREG	Evgen Pharma PLC Final Report from Phase 1b PK/PD study
03/8/2023	06:38	UKREG	Evgen Pharma PLC Rule 17 Disclosure
02/8/2023	04:28	ALNC	IN BRIEF: Evgen Pharma shares drop on ending of license..
02/8/2023	01:00	UKREG	Evgen Pharma PLC Return of rights to Sulforadex from..
21/7/2023	06:03	UKREG	Evgen Pharma PLC Result of AGM
27/6/2023	04:01	ALNC	Evgen Pharma's SFX-01 has positive effects for treating a..
27/6/2023	01:00	RNSNON	Evgen Pharma PLC SFX-01 radiosensitisation effect confirmed..
20/6/2023	07:59	UKREG	Evgen Pharma PLC Notice of AGM & Posting of Annual Report
19/6/2023	04:05	ALNC	Evgen collaborator receives grant from KWF Dutch Cancer..
19/6/2023	01:00	UKREG	Evgen Pharma PLC Grant Success for Glioblastoma studies
07/6/2023	05:41	ALNC	Evgen Pharma confident amid Stalicla deal; CFO Moulson to..
07/6/2023	01:00	UKREG	Evgen Pharma PLC Final Results
26/5/2023	05:00	UKREG	Evgen Pharma PLC Notice of Results
22/3/2023	06:10	ALNC	IN BRIEF: Evgen Pharma shares up as pharmacokinetic data..
22/3/2023	02:00	UKREG	Evgen Pharma PLC Preliminary results from Phase 1b study
16/3/2023	11:35	ALNC	Evgen notes evidence of radiosensitisation by SFX-01 in..
16/3/2023	09:00	UKREG	Evgen Pharma PLC Price Monitoring Extension
16/3/2023	06:05	UKREG	Evgen Pharma PLC Second Price Monitoring Extn
16/3/2023	06:00	UKREG	Evgen Pharma PLC Price Monitoring Extension
16/3/2023	02:00	RNSNON	Evgen Pharma PLC Further evidence of radiosensitisation by..
13/3/2023	07:18	ALNC	SUMMARY: London listings with exposure to Silicon Valley..
13/3/2023	02:00	UKREG	Evgen Pharma PLC No exposure to Silicon Valley Bank
25/1/2023	04:40	ALNC	Evgen Pharma completes dosing of clinical trial for SFX-01..
25/1/2023	01:00	UKREG	Evgen Pharma PLC Clinical trial update
14/12/2022	11:08	UKREG	Evgen Pharma PLC Grant of Options - Director/PDMR..